Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1979 1
1981 1
1985 3
1987 2
1988 1
1989 6
1990 12
1991 7
1992 3
1993 2
1994 3
1995 4
1996 7
1997 5
1998 5
1999 7
2000 7
2001 5
2002 14
2003 14
2004 14
2005 12
2006 8
2007 12
2008 12
2009 17
2010 27
2011 35
2012 37
2013 40
2014 31
2015 50
2016 25
2017 41
2018 35
2019 36
2020 52
2021 69
2022 67
2023 51
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

710 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for P. lin sy
Search for P. Linsy instead (1 results)
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.
Tan DJH, Ng CH, Lin SY, Pan XH, Tay P, Lim WH, Teng M, Syn N, Lim G, Yong JN, Quek J, Xiao J, Dan YY, Siddiqui MS, Sanyal AJ, Muthiah MD, Loomba R, Huang DQ. Tan DJH, et al. Among authors: lin sy. Lancet Oncol. 2022 Apr;23(4):521-530. doi: 10.1016/S1470-2045(22)00078-X. Epub 2022 Mar 4. Lancet Oncol. 2022. PMID: 35255263 Free PMC article.
Patients with NAFLD-related hepatocellular carcinoma were older (p<0.0001), had higher BMI (p<0.0001), and were more likely to present with metabolic comorbidities (diabetes [p<0.0001], hypertension [p<0.0001], and hyperlipidaemia [p …
Patients with NAFLD-related hepatocellular carcinoma were older (p<0.0001), had higher BMI (p<0.0001), and were more lik …
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
McGrail DJ, Pilié PG, Rashid NU, Voorwerk L, Slagter M, Kok M, Jonasch E, Khasraw M, Heimberger AB, Lim B, Ueno NT, Litton JK, Ferrarotto R, Chang JT, Moulder SL, Lin SY. McGrail DJ, et al. Among authors: lin sy. Ann Oncol. 2021 May;32(5):661-672. doi: 10.1016/j.annonc.2021.02.006. Epub 2021 Mar 15. Ann Oncol. 2021. PMID: 33736924 Free PMC article.
RESULTS: In cancer types where CD8 T-cell levels positively correlated with neoantigen load, such as melanoma, lung, and bladder cancers, TMB-H tumors exhibited a 39.8% ORR to ICB [95% confidence interval (CI) 34.9-44.8], which was significantly higher than that observed in low T …
RESULTS: In cancer types where CD8 T-cell levels positively correlated with neoantigen load, such as melanoma, lung, and bladder cancers, TM …
Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy.
Song L, Liu Z, Hu HH, Yang Y, Li TY, Lin ZZ, Ye J, Chen J, Huang X, Liu DT, Zhou J, Shi Y, Zhao H, Xie C, Chen L, Song E, Lin SY, Lin SC. Song L, et al. Among authors: lin sy. Nat Commun. 2020 Nov 17;11(1):5842. doi: 10.1038/s41467-020-19694-w. Nat Commun. 2020. PMID: 33203880 Free PMC article.
Re-expression of 3YF-lipin-1 in PyVT;Lpin1(-/-) mice fails to promote progression and metastasis of mammary tumours. Human breast tumours exhibit increased p-Tyr-lipin-1 levels compared to the adjacent tissues. Importantly, statistical analyses show that levels of p …
Re-expression of 3YF-lipin-1 in PyVT;Lpin1(-/-) mice fails to promote progression and metastasis of mammary tumours. Human breast tumours ex …
TRP channels in mechanosensation.
Lin SY, Corey DP. Lin SY, et al. Curr Opin Neurobiol. 2005 Jun;15(3):350-7. doi: 10.1016/j.conb.2005.05.012. Curr Opin Neurobiol. 2005. PMID: 15922584 Review.
Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
Wu LQ, Huang LF, Yang H, Ye BD, Sheng JP, Yu QH, Yang Y, Jia JS, Zhang DH, Lin SY, He GS, Li JY. Wu LQ, et al. Among authors: lin sy. Ann Hematol. 2023 Aug;102(8):2015-2023. doi: 10.1007/s00277-023-05256-9. Epub 2023 May 17. Ann Hematol. 2023. PMID: 37193759 Review.
At six months, the overall response rate and complete response were significantly higher in the HID-HSCT group than those in the IST group (84.0% vs. 40.0%, P = 0.001; 80.0% vs. 17.1%, P = 0.001). With a median follow-up of 18.5 months (4.3~30.8 months), patients in …
At six months, the overall response rate and complete response were significantly higher in the HID-HSCT group than those in the IST group ( …
Predictors of Completion of Sublingual Immunotherapy.
Hura N, Song S, Kamil RJ, Pierre G, Lin SY. Hura N, et al. Among authors: lin sy. Laryngoscope. 2021 Jul;131(7):E2111-E2115. doi: 10.1002/lary.29272. Epub 2020 Nov 12. Laryngoscope. 2021. PMID: 33179776

The odds of SLIT completion were twice as high with each additional clinic visit (P < .001), and twice as high when the dosage was increased during therapy (P = .06). Pediatric patients younger than age 12 with a history of asthma were over five times more likely

…

The odds of SLIT completion were twice as high with each additional clinic visit (P < .001), and twice as high when the dosage was

…
Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial.
Teng J, Paller AS, Bruckner AL, Murrell DF, Mellerio JE, Bodemer C, Martinez AE, Lugo-Somolinos A, Sprecher E, Laimer M, Wally V, Chan YM, Lin SY, Spellman M, Bauer JW. Teng J, et al. Among authors: lin sy. J Drugs Dermatol. 2023 Jun 1;22(6):599-604. doi: 10.36849/JDD.7108. J Drugs Dermatol. 2023. PMID: 37276163 Clinical Trial.
RESULTS: There was no difference in the proportion of patients achieving either key efficacy endpoint between the diacerein 1% and vehicle groups (P&gt;0.05). No difference in treatment emergent adverse events were noted between the groups. ...
RESULTS: There was no difference in the proportion of patients achieving either key efficacy endpoint between the diacerein 1% and vehicle g …
Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review.
Yong JN, Lim WH, Ng CH, Tan DJH, Xiao J, Tay PWL, Lin SY, Syn N, Chew N, Nah B, Dan YY, Huang DQ, Tan EXX, Sanyal AJ, Noureddin M, Siddiqui MS, Muthiah MD. Yong JN, et al. Among authors: lin sy. Clin Gastroenterol Hepatol. 2023 Jan;21(1):45-54.e6. doi: 10.1016/j.cgh.2021.11.014. Epub 2021 Nov 18. Clin Gastroenterol Hepatol. 2023. PMID: 34801743 Review.
Overall survival was comparable between LT recipients for NASH vs non-NASH (hazard ratio, 0.910; 95% CI, 0.760 to 1.10; P = .34). Meta-regression showed that a higher model for end-stage liver disease score was associated with significantly worse overall survival in NASH c …
Overall survival was comparable between LT recipients for NASH vs non-NASH (hazard ratio, 0.910; 95% CI, 0.760 to 1.10; P = .34). Met …
Delayed coloanal anastomosis as a stoma-sparing alternative to immediate coloanal anastomosis: A systematic review and meta-analysis.
Lin SY, Ow ZGW, Tan DJH, Tay PWL, Lim SY, Xiao J, Wong NW, Wong KY, Foo FJ, Chong CS. Lin SY, et al. ANZ J Surg. 2022 Mar;92(3):346-354. doi: 10.1111/ans.16964. Epub 2021 May 24. ANZ J Surg. 2022. PMID: 34031967 Review.

RESULTS: Patients undergoing DCA were significantly less likely to require diverting stoma construction as compared to ICA (odds ratio [OR] = 0.04; confidence interval [CI]: 0.02-0.07; P < 0.001). Overall postoperative morbidity (OR = 0.50; 95% CI: 0.23-1.12; P =

…
RESULTS: Patients undergoing DCA were significantly less likely to require diverting stoma construction as compared to ICA (odds ratio [OR] …
Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson's disease: a meta-analysis.
Xie CL, Zhang YY, Wang XD, Chen J, Chen YH, Pa JL, Lin SY, Lin HZ, Wang WW. Xie CL, et al. Among authors: lin sy. Neurol Sci. 2015 Aug;36(8):1319-29. doi: 10.1007/s10072-015-2253-7. Epub 2015 May 17. Neurol Sci. 2015. PMID: 25981231 Review.

The results showed that L-dopa alone could evidently improve the UPDRS part I (p = 0.005), part II (p < 0.0001), part III (p < 0.0001) and UPDRS total score (p = 0.004) compared with L-dopa-sparing therapy in PD patients. Meanwhile, a reduced ris

…

The results showed that L-dopa alone could evidently improve the UPDRS part I (p = 0.005), part II (p < 0.0001), part III (

…
710 results